跳至主要内容
临床试验/CTRI/2008/091/000079
CTRI/2008/091/000079招募中2 期

Role of a synbiotic/ probiotic (VSL#3) in the prevention of spontaneous bacterial peritonitis in cirrhotic Patients

Dept of Gastroenterology0 个研究点目标入组 250 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All patients with liver cirrhosis with ascites having either history of prior SBP or ascitic fluid protein <1 gm/dl will be included in the study irrespective of etiology.
  • Cirrhosis will be diagnosed on the basis of clinical, radiological and/or histological ground Patients will be evaluated with complete medical history, clinical examination and baseline laboratory parameters: liver function test, renal function test, ascitic fluid analysis and disease specific further investigations as required. Cirrhosis will be classified according to Childâ??s-Pugh classification system.

排除标准

  • -Patients chronically treated with antibiotics (that disturb/alter normal gut flora) or lactulose during past 30 days.
  • -Patients having risk factor of small intestinal bacterial overgrowth other than cirrhosis - diabetes mellitus, history of abdominal surgery, immunomodulatory drugs, Alcoholic cirrhotics who continue to take alcohol.
  • -Patients with active or recent G.I. bleed (within prior 7 days).
  • -Patients with advanced HCC, renal failure and portal vein thrombosis

研究者

发起方
Dept of Gastroenterology

相似试验